Related Experiment Video
Updated: Aug 6, 2026

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
Published on: January 27, 2018
DYT1 dystonia increases risk taking in humans
David Arkadir1, Angela Radulescu2,3, Deborah Raymond4
1Department of Neurology, Hadassah Medical Center and the Hebrew University, Jerusalem, Israel.
DYT1 dystonia patients exhibit abnormal risk-taking behaviors. This finding links changes in brain plasticity within the striatum to altered decision-making in humans with this genetic motor disorder.
Area of Science:
- Neuroscience
- Genetics
- Behavioral Science
Background:
- Linking synaptic plasticity to observable behaviors is challenging.
- DYT1 dystonia, a genetic motor disorder, involves altered corticostriatal synaptic plasticity in rodent models, with increased long-term potentiation and decreased long-term depression.
- Computational models suggest this asymmetric synaptic plasticity predicts risk-taking behavior.
Purpose of the Study:
- To investigate whether DYT1 dystonia patients exhibit abnormal risk-taking behavior.
- To explore the correlation between risk-taking behavior and disease severity in DYT1 dystonia.
- To support the role of striatal plasticity in human choice behavior.
Main Methods:
- Behavioral assessment of risk-taking in probabilistic tasks in human patients with DYT1 dystonia.
- Correlation analysis between observed risk-taking behavior and clinical measures of disease severity.
Main Results:
- DYT1 dystonia patients demonstrated abnormal risk-taking behavior.
- The degree of abnormal risk-taking correlated significantly with the severity of the dystonia.
Conclusions:
- The study provides evidence for abnormal risk-taking in human DYT1 dystonia.
- Findings support the hypothesis that altered striatal plasticity influences choice behavior in humans.
- Connects molecular/synaptic changes in a genetic disorder to complex human behavior.
More Related Videos
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Parkinson Disease l: Introduction
Huntington Disease l: Introduction
Alterations in Muscle Tone ll